Utama › Diabetes Jenis 2
Kajian klinikal Diabetes Jenis 2 sedang mengambil peserta di AS
240 kajian untuk Diabetes Jenis 2 sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- San Antonio, TX37 kajian
- Houston, TX31 kajian
- Orlando, FL24 kajian
- Boston, MA20 kajian
- Miami, FL19 kajian
- Chicago, IL19 kajian
- Dallas, TX19 kajian
- Columbus, OH18 kajian
- Las Vegas, NV18 kajian
- Atlanta, GA17 kajian
- San Diego, CA17 kajian
- Los Angeles, CA16 kajian
- Birmingham, AL16 kajian
- New York City, NY16 kajian
- Philadelphia, PA15 kajian
- Arlington, VA15 kajian
- Jacksonville, FL15 kajian
- Havelock, NC13 kajian
- Cincinnati, OH12 kajian
- Washington, DC12 kajian
- Austin, TX12 kajian
- Indianapolis, IN12 kajian
- Aurora, CO11 kajian
- Durham, NC11 kajian
- Long Beach, CA11 kajian
- Kansas City, MO11 kajian
- Albuquerque, NM11 kajian
- Salt Lake City, UT11 kajian
- Omaha, NE11 kajian
- Ann Arbor, MI10 kajian
- Baltimore, MD10 kajian
- Hialeah, FL10 kajian
- Oklahoma City, OK10 kajian
- Wichita, KS10 kajian
- Little Rock, AR10 kajian
- Deltona, FL10 kajian
- Tucson, AZ10 kajian
- Pittsburgh, PA10 kajian
- New Haven, CT10 kajian
- Concord, CA10 kajian
Mengikut negeri
- Alabama22 kajian
- Arizona22 kajian
- Arkansas11 kajian
- California67 kajian
- Colorado16 kajian
- Connecticut14 kajian
- Florida48 kajian
- Georgia34 kajian
- Hawaii7 kajian
- Idaho12 kajian
- Illinois30 kajian
- Indiana18 kajian
- Iowa10 kajian
- Kansas15 kajian
- Kentucky12 kajian
- Louisiana15 kajian
- Maryland26 kajian
- Massachusetts29 kajian
- Michigan27 kajian
- Minnesota17 kajian
- Mississippi9 kajian
- Missouri20 kajian
- Montana4 kajian
- Nebraska14 kajian
- Nevada18 kajian
- New Jersey15 kajian
- New Mexico12 kajian
- New York33 kajian
- North Carolina36 kajian
- North Dakota6 kajian
- Ohio41 kajian
- Oklahoma13 kajian
- Oregon7 kajian
- Pennsylvania30 kajian
- Rhode Island3 kajian
- South Carolina20 kajian
- South Dakota3 kajian
- Tennessee18 kajian
- Texas58 kajian
- Utah19 kajian
- Virginia26 kajian
- Washington20 kajian
- West Virginia7 kajian
- Wilayah Columbia7 kajian
- Wisconsin9 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05279729Efficacy of Using Mobile Health Applications for Health
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05589155Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
Mengambil peserta
Umur 18 hingga 60 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07641361Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06906640Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06906627A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07783802A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07564414Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07754461A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
Mengambil peserta
Umur 18 ke atas · Wanita · Dikemas kini 29 Sep 2026 · NCT05909046NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Mengambil peserta
Semua umur · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06593327A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07223333A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 55 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06112418Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06836479Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07399678A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07776509ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Mengambil peserta
Umur 8 hingga 21 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05463289A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07784270Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT02969798Phenotyping Genetic Risk for Type 2 Diabetes
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 10 hingga 70 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT04024631Improving the Collaborative Health of Adult Dyads
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT05370014Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 18 hingga 45 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07494084Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.